Editorial

Editorial
  • Güven Aslan
Bull Urooncol 2013; 12: 0-0
Full
Text
Editorial
  • Güven Aslan
Bull Urooncol 2013; 12: 0-0
Full
Text
Editorial
  • Güven Aslan
Bull Urooncol 2013; 12: 0-0
Full
Text
Editorial
  • Talha Müezzinoglu
Bull Urooncol 2013; 12: 0-0
Full
Text
Editorial
  • Talha Müezzinoglu
Bull Urooncol 2012; 11: 0-0
Full
Text
Editorial
  • Talha Müezzinoglu
Bull Urooncol 2012; 11: 0-0
Full
Text
Editorial
  • Talha Müezzinoglu
Bull Urooncol 2012; 11: 0-0
Full
Text
Editorial
  • Talha Müezzinoglu
Bull Urooncol 2012; 11: 0-0
Full
Text
Editorial
  • Talha Müezzinoglu
  • Turgut ALKIBAY
Bull Urooncol 2011; 10: 0-0
Full
Text
Editorial
  • Talha Müezzinoglu
Bull Urooncol 2011; 10: 0-0
Full
Text
Editorial
  • Talha Müezzinoglu
Bull Urooncol 2011; 10: 0-0
Full
Text
Editorial
  • Güven Aslan
Bull Urooncol 2014; 13: 0-0
Full
Text
Editorial
  • Güven Aslan
Bull Urooncol 2015; 14: 0-0
Full
Text
Editorial
  • Murat Kosan
Bull Urooncol 2015; 14: 0-0
Full
Text
Editorial
  • Murat Kosan
Bull Urooncol 2015; 14: 0-0
Full
Text
Editorial
  • Murat Koşan
Bull Urooncol 2016; 15: 0-0
Full
Text
Editorial
  • Murat Koşan
Bull Urooncol 2016; 15: 0-0
Full
Text
Editorial
  • Murat Koşan
Bull Urooncol 2017; 16: 0-0
Full
Text
Renal hücreli karsinomda tümör belirleyicilerindeki gelişmeler
  • Murat Lekili
  • Oktay Üçer
Bull Urooncol 2009; 8: 3-7
Full
Text
Defining the ideal patient for active surveillance in localized prostate cancer and the impact of active surveillance studies on clinical practice
  • Ayhan Dirim
  • Hakan Özkardeş
Bull Urooncol 2011; 10: 41-46
Full
Text
Ongoing Studies of the Bladder Tumor Study Group: An Overview
  • N. Aydın Mungan
  • İlker Tınay
Bull Urooncol 2014; 13: 67-69 DOI: 10.4274/UOB.01
Full
Text

Review

Is radical cystectomy the gold standard?
  • Binhan Kağan Aktaş
  • Ali Memiş
Bull Urooncol 2013; 12: 1-5
Full
Text